FDC Limited Posts Strong FY 2025-26 Growth

Consolidated Revenue: Rs 2,170.93 crore | Consolidated PAT: Rs 281.42 crore

Reader Takeaway: Robust US market expansion drives revenue growth, though global regulatory compliance remains a critical performance monitor.

What just happened

FDC Limited has released its Annual Report for FY 2025-26, highlighting a period of steady financial growth and operational expansion. The company achieved a consolidated revenue of Rs 2,170.93 crore, marking an increase from Rs 2,108.12 crore in the prior fiscal year. Consolidated Profit After Tax (PAT) stood at Rs 281.42 crore compared to Rs 266.79 crore in FY 2024-25.

Why this matters

The company’s performance highlights successful navigation of international markets. The International Formulations segment grew by 23.5% year-on-year, with sales in the US market more than doubling to Rs 70.60 crore from Rs 26.60 crore. This shift indicates a strengthening footprint in highly regulated global markets.

Corporate Actions and Governance

The Board of Directors confirmed an interim dividend of Rs 5 per equity share as the final dividend for the year. Leadership changes were also finalized: Mr. Mohan A. Chandavarkar took charge as Chairman & Managing Director effective April 1, 2026, succeeding Mr. Uday Kumar Gurkar. Additionally, Mr. Vishal D. Shah assumed the role of CFO in October 2025.

Operational Highlights

FDC has leaned into R&D and sustainability. The company secured several USFDA ANDA approvals for ophthalmic and oral products. On the sustainability front, FDC commissioned a biomass briquette-fired boiler and increased its rooftop solar capacity to 3.3 MWp.

What to track next

Investors should monitor the company's ability to maintain its growth trajectory in the US market and the integration of new product launches into their existing revenue stream.